Booster DJ, Hortobagyi GN: Treatment of locally advanced breast cancer. Semin Oncol. 1992, 19: 278-285.
Google Scholar
Fornari FA, Randolph JK, Yalowich JC, Ritke MK, Gewirtz DA: Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol Pharmacol. April 1994, 45 (4): 649-656.
CAS
PubMed
Google Scholar
Ayaz SA, Bhandari U, Pillai KK, et al: Influence of DL α-lipoic acid and vitamin E against doxorubicin - induced biochemical and histological changes in the cardiac tissue of rat. Indian J Pharmacol. 2004, 37 (5): 294-299.
Google Scholar
Momparler RL, Karon M, Siegel SE, Avila F: Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. Cancer Res. August 1976, 36 (8): 2891-2895.
CAS
PubMed
Google Scholar
Tan C, Tasaka H, Yu KP, Murphy ML, Karnofsky DA: Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. Cancer. March 1967, 20 (3): 333-353. 10.1002/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K.
Article
CAS
PubMed
Google Scholar
Thomas X, Le QH, Fiere D: Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia. Ann Hematol. 2002, 81 (9): 504-507. 10.1007/s00277-002-0534-8.
Article
CAS
PubMed
Google Scholar
Baguely BC: A brief history of cancer chemotherapy. Anticancer drug development. 2001, London, UK: Elsever Inc. Academic Press, 1-11. 36
Google Scholar
Berthiaume JM, Wallace KB: Adriamycin -induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol. 2007, 23: 15-25. 10.1007/s10565-006-0140-y.
Article
CAS
PubMed
Google Scholar
Nozaki N, Shishido T, Takeishi Y, Kubota I: Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice. Circulation. 2004, 110 (18): 2869-2874. 10.1161/01.CIR.0000146889.46519.27.
Article
CAS
PubMed
Google Scholar
Doroshow JH, Locker JY, Myers CE, et al: Enzymetic defence of the mouse heart against reactive oxygen metabolites :alterations produced by doxorubicin. J clinic Invest. 1980, 65: 128-135. 10.1172/JCI109642.
Article
CAS
Google Scholar
Agnoletti L, Curello S, Bachetti T, et al: Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. Circulation. 1999, 100: 1983-1991. 10.1161/01.CIR.100.19.1983.
Article
CAS
PubMed
Google Scholar
Shinozawa S, Gomita Y, Araki Y: Effect of high-dose α-tocopherol acetate pretreatment on adriamycin (doxorubicin) induced toxicity and tissue distribution. Physiol Chem Phys Med NMR. 1988, 20: 329-335.
CAS
PubMed
Google Scholar
Kagota S, Tada Y, Kubota Y, et al: Peroxynitrite is involved in the Dysfunction of Vasorelaxation in SHR/NDmcr-cp Rats, Spontaneously Hypertensive Obese Rats. J Cardiovasc Pharmacol. 2007, 50 (6): 677-685. 10.1097/FJC.0b013e3181583d80.
Article
CAS
PubMed
Google Scholar
Nasser Ghaly Yousif, Al-amran Fadhil G: Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice. BMC Cardiovasc Disord. 2011, 11: 62-10.1186/1471-2261-11-62.
Article
Google Scholar
David Moore S, McCabe George P: Introduction to practice statistic. 1998, 3
Google Scholar
Kim SY, Kim SJ, Kim BJ, Rah SY, Chung SM, Im MJ, Kim UH: Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in rat cardiomyocytes. Exp Mol Med. 2006, 38 (5): 535-545.
Article
CAS
PubMed
Google Scholar
Singh N, Dhalla AK, Seneviratne C, Singal PK: Oxidative stress and heart failure. Mol Cell Biochem. 1995, 147: 77-81. 10.1007/BF00944786.
Article
CAS
PubMed
Google Scholar
Gupta M, Singal PK: Time course of structure, function, and metabolic changes due to an exogenous source of oxygen metabolites in rat heart. Can J Physiol Pharmacol. 1989, 67: 1549-59. 10.1139/y89-250.
Article
CAS
PubMed
Google Scholar
Yousif NG, Ao L, Li J, Aly A, Austin E, Fullerton DA, Meng X: Myocardial Tissue TLR4 Plays a Major Role in Mediating Myocardial Injury Following Cold Ischemia and Reperfusion Through Up-regulation Of MCP-1. ASC 2011 Abstract, Quick shot. Transplant Immunol (Transplant/Immunology).
Siveski-Iliskovic N, Kaul N, Singal PK: Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation. 1994, 89: 2829-2835. 10.1161/01.CIR.89.6.2829.
Article
CAS
PubMed
Google Scholar
Sugiyama T, Cam H, Verdel A, Moazed D, Grewal SI: RNA-dependent RNA polymerase is an essential component of a self-enforcing loop coupling heterochromatin assembly to siRNA production. Proc Natl Acad Sci. 2005, 102: 152-157. 10.1073/pnas.0407641102.
Article
CAS
PubMed
Google Scholar
Muzaffar Iqbal, Kiran Dubey, Tarique Anwer, et al: Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats. Pharmacol Rep. 2008, 60: 382-390.
Google Scholar
Olson RD, Mushlin PS: Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB. 1990, 4: 3076-3086.
CAS
Google Scholar
Sridharan S, Shyamaladevi CS: Protective effect of N-acetylcysteine against gamma ray induced damages in rats {biochemical evaluations. Indian J Exp Biol. 2002, 40: 181-186.
CAS
PubMed
Google Scholar
Oliveira Paulo J, Bjork James A, Santos MS, et al: Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity. Toxicol Appl Pharmacol. 2004, 200: 159-168. 10.1016/j.taap.2004.04.005.
Article
CAS
PubMed
Google Scholar
Lores AS, Llesuy S, Cutrin JC, et al: Oxidative stress by acute acetaminophen administration in mouse liver. Free Radic Biol Med. 1995, 19: 303-310. 10.1016/0891-5849(95)00023-Q.
Article
Google Scholar
Panjrath GS, Patel V, Valdiviezo CI, et al: Potentiation of doxorubicin cardiotoxicity by iron loading in a rodent model. J Am Coll Cardiol. 2007, 49: 2457-2464. 10.1016/j.jacc.2007.02.060.
Article
CAS
PubMed
Google Scholar
Jung K-H, Chu K, Lee S-T, et al: Blockade of AT1 Receptor Reduces Apoptosis, Inflammation, and Oxidative Stress in Normotensive Rats with Intracerebral Hemorrhage. J Pharmacol Exp Ther. 2007, 322 (3): 1051-1058. 10.1124/jpet.107.120097.
Article
CAS
PubMed
Google Scholar
Thai H, Wollmuth J, Goldman S, Gaballa M: Angiotensin subtype 1 receptor blockade improves vasorelaxation in heart failure by up-regulation of endothelial nitric-oxide synthase via activation of the AT2 receptor. J Pharmacol Exp Ther. 2003, 307: 1171-1178. 10.1124/jpet.103.054916.
Article
CAS
PubMed
Google Scholar
Wright JW, Reichert JR, Davis CJ, Harding JW: Neural plasticity and the brain renin-angiotensin system. Neurosci Biobehav Rev. 2002, 26: 529-552. 10.1016/S0149-7634(02)00019-2.
Article
CAS
PubMed
Google Scholar